Free Trial

Janux Therapeutics (JANX) Insider Trading & Ownership

Janux Therapeutics logo
$14.58 -0.03 (-0.17%)
As of 02:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Janux Therapeutics (NASDAQ:JANX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$1.00M
Get JANX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Janux Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JANX Insider Buying and Selling by Quarter

Janux Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/11/2026Sell2,038$14.17$28,878.46  
1/2/2026Sell1,879$13.73$25,798.67  
1/2/2026Sell2,401$13.73$32,965.73  
1/2/2026Sell8,072$13.73$110,828.56  
1/2/2026Sell1,462$13.73$20,073.26  
1/2/2026Sell2,505$13.73$34,393.65  
1/2/2026Sell2,714$13.73$37,263.22  
12/1/2025Sell3,333$32.98$109,922.34  
11/14/2025Sell3,333$30.00$99,990.00  
10/28/2025Sell16,665$30.06$500,949.90  
(Data available from 1/1/2013 forward)

JANX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Janux Therapeutics includes Andrew Hollman Meyer, Charles M Winter, David Alan Campbell, Jay Lichter, Maria Dobek, Ra Capital Management, L.P., Thomas Diraimondo, Tighe Reardon, Ventures Xi L.P. Avalon, and Zachariah Mciver. Learn more on insiders at JANX.

7.90% of Janux Therapeutics stock is owned by insiders. Learn more on JANX's insider holdings.

The following insider purchased JANX shares in the last 24 months: Ra Capital Management, L.P. ($67,589,565.00).

Insiders have purchased a total of 1,651,948 JANX shares in the last 24 months for a total of $67,589,565.00 bought.

The following insiders have sold JANX shares in the last 24 months: Andrew Hollman Meyer ($4,221,389.78), Charles M Winter ($32,965.73), David Alan Campbell ($6,606,828.56), Jay Lichter ($82,125,000.00), Maria Dobek ($48,951.72), Thomas Diraimondo ($34,393.65), Tighe Reardon ($45,043,974.75), Ventures Xi L.P. Avalon ($51,575,441.04), and Zachariah Mciver ($37,263.22).

Insiders have sold a total of 3,561,681 Janux Therapeutics shares in the last 24 months for a total of $189,726,208.45 sold.



This page (NASDAQ:JANX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners